Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Utilize your home equity as a powerful tool to eliminate debt. Explore options that can help you regain financial stability.
23,247 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
The AI boom has turned Nvidia and AMD into poster children for opportunity—and risk. This guide breaks down the signa...
UBS boosts its price target on Xcel Energy to $89 while maintaining a Buy rating, saying the stock could year-end hig...
Two top banks boosted Amazon price targets on March 25, 2026, citing a clear acceleration in AWS AI demand and a mult...
The Baupost founder made a bold, selective move: trim a large Alphabet stake and pivot to a fintech name that slumped...
Palantir faces a pivotal moment as 2025 results reinforce growth in AI-related revenue, yet lofty valuations keep inv...
Morgan Stanley halves Lucid's price target to $5, keeping an Underweight rating as production stoppages and a leaders...
A closer look at how Lawrence Calcano built iCapital into a leading wealth-tech platform for alternatives. Learn the ...
FHA delinquencies are climbing even as overall mortgage distress remains contained. Analysts warn this could become a...
Super Micro Computer jumped 5% after posting a margin beat and raised guidance. The move fans the debate over a poten...
Bitmine Immersion Technologies slows weekly ETH purchases while maintaining a bullish stance. Tom Lee signals a forth...
A leading AI scientist cautions that hyperintelligent machines with their own preservation goals could imperil humani...